Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-03-14

Clinical Trial Update: The Influence of ABCB1、CYP3A4、CYP3A5、POR Genetic Polymorphism and Other Factors on Tacrolimus Blood Concentration

View source ↗

Summary

This clinical trial update examines how genetic polymorphisms in ABCB1, CYP3A4, CYP3A5, POR and other factors influence tacrolimus blood concentration in kidney…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tacrolimus (Tacrolimus)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Kidney Transplantation, Liver Transplantation | Status: UNKNOWN